Headlands Technologies’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.2K Buy
+10,489
New +$26.7K ﹤0.01% 687
2025
Q3
Sell
-37,914
Closed -$189K 872
2025
Q2
$189K Buy
37,914
+23,084
+156% +$100K 0.02% 485
2025
Q1
$65.4K Buy
14,830
+10,095
+213% +$47.4K 0.01% 657
2024
Q4
$22K Buy
+4,735
New +$26K ﹤0.01% 924
2023
Q3
Sell
-5,241
Closed -$28.9K 1027
2023
Q2
$28.9K Buy
+5,241
New +$28.2K 0.01% 529

Other funds holding GDRX

Headlands Technologies's GDRX Position: Q2 2026 in Review

Headlands Technologies opened a new position in GoodRx Holdings (GDRX) in Q2 2026: 10,489 shares worth $30.2K. The stake represents ﹤0.01% of the portfolio and ranks #687 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in GDRX as recently as Q2 2025.

Headlands Technologies first reported a position in GDRX in Q2 2023 and has held it in 5 quarters since. The position peaked at $189K in Q2 2025. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Headlands Technologies held 10,489 shares of GoodRx Holdings worth $30.2K as of Q2 2026.
  • GoodRx Holdings was a new Headlands Technologies position in Q2 2026.
  • GoodRx Holdings made up ﹤0.01% of Headlands Technologies's portfolio in Q2 2026, its #687 holding.
  • Headlands Technologies first reported a position in GoodRx Holdings in Q2 2023 and has held it in 5 quarters since.
  • Headlands Technologies's GoodRx Holdings position peaked at $189K in Q2 2025.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.